Crystal structure from X-ray powder diffraction data, DFT-D calculation, Hirshfeld surface analysis, and energy frameworks of (RS)-trichlorme­thia­zide

The structure of racemic (RS)-trichlorme­thia­zide [systematic name: (RS)-6-chloro-3-(di­chloro­meth­yl)-1,1-dioxo-3,4-di­hydro-2H-1λ(6),2,4-benzo­thia­di­azine-7-sulfonamide], C(8)H(8)Cl(3)N(3)O(4)S(2) (RS-TCMZ), a diuretic drug used in the treatment of oedema and hypertension, was determined from laboratory X-ray powder diffraction data using DASH [David et al. (2006 ▸). J. Appl. Cryst. 39, 910–915.], refined by the Rietveld method with TOPAS-Academic [Coelho (2018 ▸). J. Appl. Cryst. 51, 210–218], and optimized using DFT-D calculations. The extended structure consists of head-to-tail dimers connected by π–π inter­actions which, in turn, are connected by C—Cl⋯π inter­actions. They form chains propagating along [101], further connected by N—H⋯O hydrogen bonds to produce layers parallel to the ac plane that stack along the b-axis direction, connected by additional N—H⋯O hydrogen bonds. The Hirshfeld surface analysis indicates a major contribution of H⋯O and H⋯Cl inter­actions (32.2 and 21.7%, respectively). Energy framework calculations confirm the major contribution of electrostatic inter­actions (E (elec)) to the total energy (E (tot)). A comparison with the structure of S-TCMZ is also presented.